{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:05:32Z","timestamp":1789967132187,"version":"4.0.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic abnormalities may contribute to in-stent restenosis (ISR) after percutaneous coronary intervention, but the comparative associations of commonly used metabolic indices with ISR within the same patient population remain incompletely characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the associations of the triglyceride-glucose (TyG) index, atherogenic index of plasma (AIP), and metabolic score for insulin resistance (METS-IR) with angiographically detected ISR and its severity, and to explore potential heterogeneity according to sex and clinical presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective, propensity-score-matched case-control study of patients undergoing follow-up coronary angiography between 2019 and 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>The propensity-score-matched cohort comprised 774 patients, including 387 patients with ISR and 387 matched controls without ISR. Angiographic severity analyses were performed among the 387 matched patients with ISR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main measures<\/jats:title>\n                    <jats:p>TyG, AIP, and METS-IR were assessed separately in multivariable models. Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC), paired DeLong testing, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Sex- and clinical-presentation analyses were considered exploratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key results<\/jats:title>\n                    <jats:p>The baseline clinical and procedural model yielded an AUC of 0.716 (95% CI 0.672\u20130.763) for ISR occurrence. Addition of TyG increased the AUC to 0.756 (95% CI 0.708\u20130.803; \u0394AUC +0.040; paired DeLong p=0.003), while addition of AIP increased the AUC to 0.772 (95% CI 0.726\u20130.806; \u0394AUC +0.056; p&amp;lt;0.001). Addition of METS-IR did not improve discrimination (AUC 0.716, 95% CI 0.671\u20130.748; p=0.642). Bootstrap analyses supported the incremental discrimination associated with TyG and AIP but not METS-IR. For ISR severity, addition of TyG or AIP produced only modest increases in AUC, neither of which was significant by paired DeLong testing. Formal interaction analyses did not demonstrate significant effect modification by sex, and analyses according to clinical presentation were limited by small subgroup sizes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this retrospective matched cohort, TyG and AIP provided incremental discriminatory information for angiographically detected ISR beyond conventional clinical and procedural factors, whereas METS-IR provided little additional value. Evidence regarding angiographic severity was less robust, and findings across sex and clinical-presentation subgroups should be considered exploratory. Prospective external validation is required before these indices can be considered for clinical risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1952213","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:29:21Z","timestamp":1789964961000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of metabolic indices with in-stent restenosis and its angiographic severity after drug-eluting stent implantation: a case-control study"],"prefix":"10.3389","volume":"17","author":[{"given":"Fabrice Yves","family":"Ndjana Lessomo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhongnan Hospital, Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Hubei Provincial Clinical Research Center for Cardiovascular Intervention","place":["Wuhan, Hubei, China"]},{"name":"Institute of Myocardial Injury","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongnan Hospital, Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Hubei Provincial Clinical Research Center for Cardiovascular Intervention","place":["Wuhan, Hubei, China"]},{"name":"Institute of Myocardial Injury","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongnan Hospital, Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Hubei Provincial Clinical Research Center for Cardiovascular Intervention","place":["Wuhan, Hubei, China"]},{"name":"Institute of Myocardial Injury","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanpeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongnan Hospital, Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Hubei Provincial Clinical Research Center for Cardiovascular Intervention","place":["Wuhan, Hubei, China"]},{"name":"Institute of Myocardial Injury","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongnan Hospital, Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Hubei Provincial Clinical Research Center for Cardiovascular Intervention","place":["Wuhan, Hubei, China"]},{"name":"Institute of Myocardial Injury","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiquan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongnan Hospital, Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Hubei Provincial Clinical Research Center for Cardiovascular Intervention","place":["Wuhan, Hubei, China"]},{"name":"Institute of Myocardial Injury","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongnan Hospital, Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Cardiovascular Center, Taikang Tongji (Wuhan) Hospital, Taikang Clinical College of Wuhan University","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.05.017","article-title":"Coronary in-stent restenosis: JACC state-of-the-art review","volume":"80","author":"Giustino","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.10.93","article-title":"Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment","volume":"8","author":"Buccheri","year":"2016","journal-title":"J Thorac Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2011.148","article-title":"Restenosis after PCI. Part 2: prevention and therapy","volume":"9","author":"Jukema","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00334-3","article-title":"Predictive factors of restenosis after coronary stent placement","volume":"30","author":"Kastrati","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12583","article-title":"The TyG index may predict the development of cardiovascular events","volume":"46","author":"S\u00e1nchez-\u00cd\u00f1igo","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(01)00263-6","article-title":"The plasma parameter log(TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma","volume":"34","author":"Dobi\u00e1sov\u00e1","year":"2001","journal-title":"Clin Biochem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0883","article-title":"METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes","volume":"178","author":"Bello-Chavolla","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010726","article-title":"The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics","volume":"97","author":"Won","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.02.004","article-title":"Sex-based differences in acute coronary syndromes: insights from invasive and noninvasive coronary technologies","volume":"9","author":"Chandrasekhar","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/cvr\/cvq394","article-title":"Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology","volume":"90","author":"Vaccarino","year":"2011","journal-title":"Cardiovasc Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000351","article-title":"Acute myocardial infarction in women: a scientific statement from the American Heart Association","volume":"133","author":"Mehta","year":"2016","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S464490","article-title":"Triglyceride-glucose index as a predictor of major adverse cardiovascular events in post-PCI patients diagnosed with in-stent restenosis","volume":"17","author":"Wang","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-021-01332-4","article-title":"Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents","volume":"20","author":"Zhu","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/00033197251372771","article-title":"Predictors of ST-segment resolution and its relationship with outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"76","author":"S\u00f6ner","year":"2025","journal-title":"Angiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12872-025-04474-5","article-title":"Association between the triglyceride-glucose index and contrast-induced nephropathy in chronic total occlusion patients undergoing percutaneous coronary intervention","volume":"25","author":"S\u00f6ner","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/eci.70167","article-title":"Atherogenic dyslipidaemia and residual cardiovascular risk: understanding the link to heart disease","volume":"56","author":"Gir\u00f3n","year":"2026","journal-title":"Eur J Clin Invest"},{"key":"B18","article-title":"Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention","volume":"5","author":"Mill\u00e1n","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14024","article-title":"Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes mellitus: results from the 4C cohort study","volume":"14","author":"Pan","year":"2023","journal-title":"J Diabetes Investig"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5606\/tgkdc.dergisi.2024.24405","article-title":"Association of body mass index with clinical outcomes in patients with acute coronary syndrome: a systematic review and meta-analysis","volume":"32","author":"Wang","year":"2024","journal-title":"Turk Gogus Kalp Damar Cerrahisi Derg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000523","article-title":"Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS","volume":"3","author":"Hess","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.307547","article-title":"Cardiovascular disease in women: clinical perspectives","volume":"118","author":"Garcia","year":"2016","journal-title":"Circ Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.116.307301","article-title":"Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases","volume":"37","author":"Arnold","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1952213\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:29:22Z","timestamp":1789964962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1952213\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":24,"alternative-id":["10.3389\/fendo.2026.1952213"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1952213","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1952213"}}